Evaluating the role of left ventricle global longitudinal strain in myocardial perfusion defect assessment

Laufer‐Perl, Michal; Arnold, Joshua H.; Moshkovits, Yonatan; Havakuk, Ofer; Shmilovich, Haim; Chausovsky, Genady; Sivan, Ayelet; Szekely, Yishay; Arbel, Yaron; Banai, Shmuel; Rozenbaum, Zach

doi:10.1007/s10554-021-02399-6

Cited by 5 publications

(2 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…GLS has demonstrated its usefulness in a number of cardiac diseases, including cardiomyopathy, myocardial infarction, HF, hypertension, and acute coronary syndrome [ 31 , 32 , 33 , 34 ]. Correlations between GLS and deleterious myocardial changes, prognostic predictors, and cardiovascular outcomes have been established in various diseases [ 31 , 32 , 33 , 34 , 35 , 36 ]. Therefore, it is not surprising that GLS assessment is recommended in the current cardio-oncology guidelines of the European Society of Cardiology [ 18 ].…”

Section: Lsmentioning

confidence: 99%

Usefulness of Longitudinal Strain to Assess Cancer Therapy-Related Cardiac Dysfunction and Immune Checkpoint Inhibitor-Induced Myocarditis

Tamura,

Tamura

2023

Pharmaceuticals

View full text Add to dashboard Cite

Longitudinal strain (LS) measured by echocardiography has been reported to be useful not only for the diagnosis and risk stratification of various cardiac diseases, but also in cardio-oncology. Most previous studies have been conducted on patients undergoing treatment with anthracyclines and human epidermal growth factor receptor 2-targeted therapies. Existing guidelines recommend that global LS (GLS) should be measured before and after the administration of cancer drugs. This recommendation is based on many reports showing that a decline in GLS is indicative of early or mild cancer therapy-related cardiac dysfunction. The main purpose of this article is to provide insight into the importance of LS in patients undergoing cancer treatment and highlight the role of LS evaluation in patients undergoing immune checkpoint inhibitor (ICI) treatment, which is being used with increasing frequency. Among cancer drug therapies, immune checkpoint inhibitors (ICIs) have an important place in cancer treatment and are used for the treatment of many types of cancer. Although the efficacy of ICIs in cancer treatment has been reported, immune-related adverse events (irAEs) have also been reported. Among these irAEs, cardiovascular complications, although rare, are recognized as important adverse events that may result in ICI treatment discontinuation. Myocarditis is one severe adverse event associated with ICIs, and it is important to standardize diagnostic and therapeutic approaches to it. Several studies have reported a relationship between LS and cardiac complications associated with ICIs which may contribute to the early diagnosis of ICI-induced cardiac complications.

show abstract

Section: Lsmentioning

confidence: 99%

Usefulness of Longitudinal Strain to Assess Cancer Therapy-Related Cardiac Dysfunction and Immune Checkpoint Inhibitor-Induced Myocarditis

Tamura,

Tamura

2023

Pharmaceuticals

View full text Add to dashboard Cite

show abstract

“…Speckle tracking echocardiography techniques, especially global longitudinal strain (GLS), are considered to be good parameters for detecting early subclinical LV dysfunction. These techniques have gained interest as potential markers of myocardial ischemia [15][16][17]. However, more research is needed before they become routine practice for this indication (Fig.…”

Section: Echocardiographymentioning

confidence: 99%

Non-invasive imaging techniques in patients with coronary chronic total occlusions: A key for successful diagnosis, revascularization, and post-intervention outcomes

et al. 2023

View full text Add to dashboard Cite

Coronary chronic total occlusions (CTOs) are a common finding on coronary angiograms of patients with coronary artery disease, with an incidence ranging from 15% to 25%. Despite this high incidence, the proper treatment strategy in those patients often remains unclear. There are some observational studies suggesting that successful revascularization of a CTO can reduce angina symptoms, improve quality of life, improve the left ventricular ejection fraction, and lower mortality. However, not all patients will benefit from revascularization. Pre-procedural assessment of left ventricular function, ischemic burden, and viability seems to be crucial for a good outcome of the revascularization. The aim of this review is to compare currently available non-invasive imaging modalities with regard to utility in evaluation of patients with CTOs. (Cardiol J 2023; 30, 6: 1038–1048)

show abstract

Echocardiography-derived regional strain for assessment of non-culprit stenosis and prediction of systolic function recovery in acute STEMI

El Kadi,

Porter,

Hopman

et al. 2024

Int J Cardiovasc Imaging

View full text Add to dashboard Cite

Evaluating the role of left ventricle global longitudinal strain in myocardial perfusion defect assessment

Cited by 5 publications

References 29 publications

Usefulness of Longitudinal Strain to Assess Cancer Therapy-Related Cardiac Dysfunction and Immune Checkpoint Inhibitor-Induced Myocarditis

Usefulness of Longitudinal Strain to Assess Cancer Therapy-Related Cardiac Dysfunction and Immune Checkpoint Inhibitor-Induced Myocarditis

Non-invasive imaging techniques in patients with coronary chronic total occlusions: A key for successful diagnosis, revascularization, and post-intervention outcomes

Echocardiography-derived regional strain for assessment of non-culprit stenosis and prediction of systolic function recovery in acute STEMI

Contact Info

Product

Resources

About